1. Liu J, Lian X, Liu F, Yan X, Cheng C, Cheng L,
et al. Identification of novel key targets and candidate drugs in oral squamous cell carcinoma. Curr Bioinform 2020;15:328–337.
2. Maruccia M, Onesti MG, Parisi P, Cigna E, Troccola A, Scuderi N. Lip cancer: a 10-year retrospective epidemiological study. Anticancer Res 2012;32:1543–1546.
5. Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F,
et al. The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012. CA Cancer J Clin 2017;67:51–64.
6. Gupta B, Bray F, Kumar N, Johnson NW. Associations between oral hygiene habits, diet, tobacco and alcohol and risk of oral cancer: a case-control study from India. Cancer Epidemiol 2017;51:7–14.
7. Gupta B, Kumar N, Johnson NW. Relationship of lifetime exposure to tobacco, alcohol and second hand tobacco smoke with upper aero-digestive tract cancers in India: a case-control study with a life-course perspective. Asian Pac J Cancer Prev 2017;18:347–356.
8. Salehiniya H, Raei M. Oral cavity and lip cancer in the world: an epidemiological review. Biomed Res Ther 2020;7:3898–3905.
9. Merchant A, Husain SS, Hosain M, Fikree FF, Pitiphat W, Siddiqui AR,
et al. Paan without tobacco: an independent risk factor for oral cancer. Int J Cancer 2000;86:128–131.
10. Pinero J, Queralt-Rosinach N, Bravo A, Deu-Pons J, Bauer-Mehren A, Baron M,
et al. DisGeNET: a discovery platform for the dynamical exploration of human diseases and their genes. Database (Oxford) 2015;2015:bav028.
11. Shen LI, Liu L, Yang Z, Jiang N. Identification of genes and signaling pathways associated with squamous cell carcinoma by bioinformatics analysis. Oncol Lett 2016;11:1382–1390.
14. Pathan M, Keerthikumar S, Ang CS, Gangoda L, Quek CY, Williamson NA,
et al. FunRich: an open access standalone functional enrichment and interaction network analysis tool. Proteomics 2015;15:2597–2601.
17. Prior SL, Griffiths AP, Baxter JM, Baxter PW, Hodder SC, Silvester KC,
et al. Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis 2006;27:945–950.
18. Park EM, Park YM, Gwak YS. Oxidative damage in tissues of rats exposed to cigarette smoke. Free Radic Biol Med 1998;25:79–86.
22. Weng LP, Wu CC, Hsu BL, Chi LM, Liang Y, Tseng CP,
et al. Secretome-based identification of Mac-2 binding protein as a potential oral cancer marker involved in cell growth and motility. J Proteome Res 2008;7:3765–3775.
23. Nagler RM, Lischinsky S, Diamond E, Klein I, Reznick AZ. New insights into salivary lactate dehydrogenase of human subjects. J Lab Clin Med 2001;137:363–369.
24. Bahar G, Feinmesser R, Shpitzer T, Popovtzer A, Nagler RM. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile. Cancer 2007;109:54–59.
25. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 2000;60:534–536.
26. Jourenkova-Mironova N, Voho A, Bouchardy C, Wikman H, Dayer P, Benhamou S,
et al. Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer 1999;81:44–48.
27. Lopez-Lazaro M. The Warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med Chem 2008;8:305–312.
28. Todd R, Donoff RB, Wong DT. The molecular biology of oral carcinogenesis: toward a tumor progression model. J Oral Maxillofac Surg 1997;55:613–623.
29. Weiner T, Cance WG. Molecular mechanisms involved in tumorigenesis and their surgical implications. Am J Surg 1994;167:428–434.
30. Spangle JM, Roberts TM, Zhao JJ. The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer. Biochim Biophys Acta Rev Cancer 2017;1868:123–131.
31. Patel KR, Vajaria BN, Begum R, Patel JB, Shah FD, Joshi GM,
et al. VEGFA isoforms play a vital role in oral cancer progression. Tumour Biol 2015;36:6321–6332.
32. Supic G, Jovic N, Zeljic K, Kozomara R, Magic Z. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients. Oral Oncol 2012;48:1171–1177.
33. Nibali L, Fedele S, D'Aiuto F, Donos N. Interleukin-6 in oral diseases: a review. Oral Dis 2012;18:236–243.
35. Peng Q, Deng Z, Pan H, Gu L, Liu O, Tang Z. Mitogen-activated protein kinase signaling pathway in oral cancer. Oncol Lett 2018;15:1379–1388.
36. Goutzanis L, Vairaktaris E, Yapijakis C, Kavantzas N, Nkenke E, Derka S,
et al. Diabetes may increase risk for oral cancer through the insulin receptor substrate-1 and focal adhesion kinase pathway. Oral Oncol 2007;43:165–173.
37. Sahibzada HA, Khurshid Z, Khan RS, Naseem M, Siddique KM, Mali M,
et al. Salivary IL-8, IL-6 and TNF-alpha as potential diagnostic biomarkers for oral cancer. Diagnostics (Basel) 2017;7:21.
38. Peisker A, Raschke GF, Fahmy MD, Guentsch A, Roshanghias K, Hennings J,
et al. Salivary MMP-9 in the detection of oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2017;22:e270–e275.
39. Ha NH, Park DG, Woo BH, Kim DJ, Choi JI, Park BS,
et al. Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs. Cytokine 2016;86:64–72.
40. Xu Q, Zhang Q, Ishida Y, Hajjar S, Tang X, Shi H,
et al. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect. Oncotarget 2017;8:9557–9571.
42. Yang B, Dong K, Guo P, Guo P, Jie G, Zhang G,
et al. Identification of key biomarkers and potential molecular mechanisms in oral squamous cell carcinoma by bioinformatics analysis. J Comput Biol 2020;27:40–54.
44. Wang J, Wang Y, Kong F, Han R, Song W, Chen D,
et al. Identification of a six-gene prognostic signature for oral squamous cell carcinoma. J Cell Physiol 2020;235:3056–3068.